Gene · 7307
Papers3,382
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
161 to 180 of 3,382
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Comparison of IPSS-R and IPSS-M in newly diagnosed myelodysplastic neoplasms: a single-center study]. | Rinsho Ketsueki | 2025 | 39924210 | PubTator, text mining | PubMed |
| TP53 Mutations in Myeloproliferative Neoplasms: Context-Dependent Evaluation of Prognostic Relevance. | Am J Hematol | 2025 | 39873146 | PubTator, text mining | PubMed |
| Clinical, immunophenotypic, and genomic findings of acute myeloid leukemia with RAM immunophenotype: Comparison with other CD56-positive acute leukemias. | EJHaem | 2025 | 39866946 | PubTator, text mining | PubMed |
| [Effect of ten-eleven translocation methylcytosine dioxygenase 2 gene mutations on the secondary myelofibrosis of JAK2V617F positive myeloproliferative neoplasms patients]. | Zhonghua Yi Xue Za Zhi | 2025 | 39828579 | PubTator, text mining | PubMed |
| U2AF1 mutation causes an oxidative stress and DNA repair defect in hematopoietic and leukemic cells. | Free Radic Biol Med | 2025 | 39814107 | PubTator, text mining | PubMed |
| Pretransplant Chromosome Genomic Array Testing Improves Prognostication for Myelofibrosis Patients Undergoing Transplantation. | Transplant Cell Ther | 2025 | 39722322 | PubTator, text mining | PubMed |
| From benign to pathogenic variants and vice versa: pyrimidine transitions at position -3 of TAG and CAG 3' splice sites. | J Hum Genet | 2025 | 39639151 | PubTator, text mining | PubMed |
| Clonal hematopoiesis in cardiovascular aging: Insights from the verona heart study. | Geroscience | 2025 | 39460851 | PubTator, text mining | PubMed |
| Hyperactivation of NF-κB signaling in splicing factor mutant myelodysplastic syndromes and therapeutic approaches. | Adv Biol Regul | 2025 | 39406588 | PubTator, text mining | PubMed |
| [Clinical Characteristics and Prognostic Significance of PTPN11 Gene Mutations in Myelodysplastic Syndromes]. | Zhongguo Shi Yan Xue Ye Xue Za Zhi | 2024 | 39743269 | PubTator, text mining | PubMed |
| CRL3ARMC5 ubiquitin ligase and Integrator phosphatase form parallel mechanisms to control early stages of RNA Pol II transcription. | Mol Cell | 2024 | 39667934 | PubTator, text mining | PubMed |
| Alternative Splicing: A Potential Therapeutic Target in Hematological Malignancies. | Hematol Rep | 2024 | 39584923 | PubTator, text mining | PubMed |
| RNA splicing as a therapeutic target in myelodysplastic syndromes. | Semin Hematol | 2024 | 39542752 | PubTator, text mining | PubMed |
| BioID proximity mapping reveals novel SAP18 interactions in the prespliceosomal complex. | Biochem Biophys Res Commun | 2024 | 39522233 | PubTator, text mining | PubMed |
| Prognostic impact of next-generation sequencing on myelodysplastic syndrome: A single-center experience. | Medicine (Baltimore) | 2024 | 39465815 | PubTator, text mining | PubMed |
| Prostate cancer cell-derived exosomes ZNF667-AS1 reduces TGFBR1 mRNA stability to inhibit Treg expansion and DTX resistance by binding to U2AF1. | Mol Med | 2024 | 39425009 | PubTator, text mining | PubMed |
| Commitment Complex Splicing Factors in Cancers of the Gastrointestinal Tract-An In Silico Study. | Bioinform Biol Insights | 2024 | 39421280 | PubTator, text mining | PubMed |
| Therapeutic strategies targeting aberrant RNA splicing in myeloid malignancies. | Br J Haematol | 2024 | 39406457 | PubTator, text mining | PubMed |
| Molecular genetic characterization of myeloid neoplasms with idic(X)(q13) and i(X)(q10). | Front Oncol | 2024 | 39391249 | PubTator, text mining | PubMed |
| The role of structure in regulatory RNA elements. | Biosci Rep | 2024 | 39364891 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7307/papers?page=9